Genetic engineering subunit oral vaccine strain for preventing porcine epidemic diarrhea as well as construction method and application thereof
A porcine epidemic diarrhea and genetic engineering technology, applied in the field of veterinary medicine, can solve the problems of biosafety consequences, unfavorable large-scale production, restricting the popularization and application of recombinant lactic acid bacteria preparations, etc., and achieve the effect of good probiotics
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0066] The probiotic comparison of embodiment 1 Lactobacillus reuteri LJ-15 strain and Lactobacillus casei
[0067] The inventor of the present invention isolated a strain of Lactobacillus reuteri from the intestinal tract of pigs, named it Lactobacillus reuteri LJ-15 strain, and preserved it in the China Type Culture Collection Center, and its strain preservation number is CCTCC NO.M2017570 . In order to use Lactobacillus reuteri LJ-15 strain as a carrier for delivering oral vaccine immune antigens, a systematic comparative analysis of its probiotics and Lactobacillus casei commonly used in this field was carried out.
[0068] 1. Inhibit diarrhea in weaned piglets
[0069] The weaned piglets were divided into 3 groups with 10 piglets in each group. The piglets in the experimental group I were fed the diet containing L. Feed the normal diet, observe the diarrhea situation of the piglets caused by weaning stress regularly every day, and continue to observe for 30 days. The s...
Embodiment 2
[0097] Example 2 Construction of a genetically engineered subunit oral vaccine strain for preventing porcine epidemic diarrhea based on porcine-derived Lactobacillus reuteri
[0098] 1. Construction of lactic acid bacteria constitutive expression plasmid pPG-T7g10-PPT
[0099] Based on the transformation of plasmid pPG612, the plasmid pPG612 was double digested with XbaI and XhoI, and the vector fragment obtained after gel recovery was connected with the HCE-T7g10-PgsA anchor-MCS-rrnBT1T2 sequence to construct a constitutive secretory expression lactic acid bacterium Vector pPG-T7g10-PPT, wherein the nucleotide sequence of the Bacillus Geobacillus toebii constitutive secretory expression promoter HCE is shown in SEQ ID NO.1, and the nucleotide sequence of the T7g10 translation enhancer is shown in SEQ ID NO.2, The nucleotide sequence of PgsAanchor is shown in SEQ ID NO.3, the transcription terminator sequence of Escherichia coli rrnBT1T2 is shown in SEQ ID NO.4, and MCS is a m...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com